| 1 |
33273827 | Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway. | 2020 |
1 |
| 2 |
29482945 | Metformin influences drug sensitivity in pancreatic cancer cells. | 2018 May |
1 |
| 3 |
28574828 | Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. | 2017 Jul 4 |
1 |
| 4 |
25834145 | Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance. | 2015 Jun |
1 |
| 5 |
23437362 | Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells. | 2013 |
1 |
| 6 |
23232026 | Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer. | 2012 Nov |
1 |